FDA NDC Directory · JSON-LD · Markdown

ZIPRASIDONE MESYLATE

NDC 51662-1564 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerHF Acquisition Co LLC, DBA HealthFirst
Marketing categoryAbbreviated NDA (generic) · App ANDA211908
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAMUSCULAR
Active ingredientsZIPRASIDONE MESYLATE (20 mg/mL)
Marketing started20210717
Package count1

External sources

Source: openFDA. Public-domain (CC0).